Published in Antimicrob Agents Chemother on October 16, 2006
Efflux-mediated drug resistance in bacteria: an update. Drugs (2009) 3.18
Role of the Mycobacterium tuberculosis P55 efflux pump in intrinsic drug resistance, oxidative stress responses, and growth. Antimicrob Agents Chemother (2009) 1.38
Ethidium bromide transport across Mycobacterium smegmatis cell-wall: correlation with antibiotic resistance. BMC Microbiol (2011) 1.06
Microbial efflux systems and inhibitors: approaches to drug discovery and the challenge of clinical implementation. Open Microbiol J (2013) 1.01
Structural plasticity and distinct drug-binding modes of LfrR, a mycobacterial efflux pump regulator. J Bacteriol (2009) 0.85
A GntR family transcription factor positively regulates mycobacterial isoniazid resistance by controlling the expression of a putative permease. BMC Microbiol (2015) 0.77
Novel TetR family transcriptional factor regulates expression of multiple transport-related genes and affects rifampicin resistance in Mycobacterium smegmatis. Sci Rep (2016) 0.76
Ribosomal mutations promote the evolution of antibiotic resistance in a multidrug environment. Elife (2017) 0.75
The envelope of mycobacteria. Annu Rev Biochem (1995) 9.33
Global trends in resistance to antituberculosis drugs. World Health Organization-International Union against Tuberculosis and Lung Disease Working Group on Anti-Tuberculosis Drug Resistance Surveillance. N Engl J Med (2001) 6.05
Resistance of Neisseria gonorrhoeae to antimicrobial hydrophobic agents is modulated by the mtrRCDE efflux system. Microbiology (1995) 4.93
Mechanisms underlying expression of Tn10 encoded tetracycline resistance. Annu Rev Microbiol (1994) 4.69
The local repressor AcrR plays a modulating role in the regulation of acrAB genes of Escherichia coli by global stress signals. Mol Microbiol (1996) 4.56
Structural basis of gene regulation by the tetracycline inducible Tet repressor-operator system. Nat Struct Biol (2000) 3.90
Efflux-mediated drug resistance in bacteria. Drugs (2004) 3.90
Expression of the multidrug resistance operon mexA-mexB-oprM in Pseudomonas aeruginosa: mexR encodes a regulator of operon expression. Antimicrob Agents Chemother (1996) 3.86
Structure of the Tet repressor-tetracycline complex and regulation of antibiotic resistance. Science (1994) 3.49
The multidrug efflux protein NorM is a prototype of a new family of transporters. Mol Microbiol (1999) 3.25
Structural mechanisms of QacR induction and multidrug recognition. Science (2001) 3.10
A protein that activates expression of a multidrug efflux transporter upon binding the transporter substrates. J Biol Chem (1994) 3.08
Regulation of bacterial drug export systems. Microbiol Mol Biol Rev (2002) 3.00
EmrR is a negative regulator of the Escherichia coli multidrug resistance pump EmrAB. J Bacteriol (1995) 2.99
Mycobacterial cell wall: structure and role in natural resistance to antibiotics. FEMS Microbiol Lett (1994) 2.73
Contribution of the MexX-MexY-oprM efflux system to intrinsic resistance in Pseudomonas aeruginosa. Antimicrob Agents Chemother (2000) 2.67
Transcriptional control of the mtr efflux system of Neisseria gonorrhoeae. J Bacteriol (1995) 2.60
Inducible NorA-mediated multidrug resistance in Staphylococcus aureus. Antimicrob Agents Chemother (1995) 2.52
QacR is a repressor protein that regulates expression of the Staphylococcus aureus multidrug efflux pump QacA. J Biol Chem (1998) 2.31
Efflux pump of the proton antiporter family confers low-level fluoroquinolone resistance in Mycobacterium smegmatis. Proc Natl Acad Sci U S A (1996) 2.27
Bile salts and fatty acids induce the expression of Escherichia coli AcrAB multidrug efflux pump through their interaction with Rob regulatory protein. Mol Microbiol (2003) 2.18
Escherichia coli-mycobacteria shuttle vectors for operon and gene fusions to lacZ: the pJEM series. J Bacteriol (1994) 2.13
A study of mycobacterial transcriptional apparatus: identification of novel features in promoter elements. J Bacteriol (1996) 2.04
Role of mycobacterial efflux transporters in drug resistance: an unresolved question. FEMS Microbiol Rev (2006) 2.02
Characterization of MexT, the regulator of the MexE-MexF-OprN multidrug efflux system of Pseudomonas aeruginosa. J Bacteriol (1999) 1.96
Electroporation of mycobacteria. Methods Mol Biol (1998) 1.88
Effects of carriage and expression of the Tn10 tetracycline-resistance operon on the fitness of Escherichia coli K12. Mol Biol Evol (1989) 1.87
MexR repressor of the mexAB-oprM multidrug efflux operon of Pseudomonas aeruginosa: identification of MexR binding sites in the mexA-mexR intergenic region. J Bacteriol (2001) 1.86
Overproduction of transposon Tn10-encoded tetracycline resistance protein results in cell death and loss of membrane potential. J Bacteriol (1989) 1.72
Permeability of the cell wall of Mycobacterium smegmatis. Mol Microbiol (1994) 1.66
Fitness of in vitro selected Pseudomonas aeruginosa nalB and nfxB multidrug resistant mutants. J Antimicrob Chemother (2002) 1.65
Selective stimulation of translation of leaderless mRNA by initiation factor 2: evolutionary implications for translation. EMBO J (2000) 1.64
Efflux pump-mediated intrinsic drug resistance in Mycobacterium smegmatis. Antimicrob Agents Chemother (2004) 1.63
The MtrR repressor binds the DNA sequence between the mtrR and mtrC genes of Neisseria gonorrhoeae. J Bacteriol (1997) 1.57
Cloning and sequencing of the gene which encodes the highly inducible acetamidase of Mycobacterium smegmatis. J Gen Microbiol (1993) 1.55
Active efflux of organic solvents by Pseudomonas putida S12 is induced by solvents. J Bacteriol (1998) 1.53
DNA gyrase genes in Mycobacterium tuberculosis: a single operon driven by multiple promoters. J Bacteriol (2002) 1.35
Antibiotic-dependent induction of Pseudomonas putida DOT-T1E TtgABC efflux pump is mediated by the drug binding repressor TtgR. Antimicrob Agents Chemother (2003) 1.34
The rRNA operons of Mycobacterium smegmatis and Mycobacterium tuberculosis: comparison of promoter elements and of neighbouring upstream genes. Microbiology (1996) 1.25
Molecular cloning and functional analysis of a novel tetracycline resistance determinant, tet(V), from Mycobacterium smegmatis. Antimicrob Agents Chemother (1998) 1.24
Interactions of the QacR multidrug-binding protein with structurally diverse ligands: implications for the evolution of the binding pocket. Biochemistry (2003) 1.00
Mycobacterial efflux pumps and chemotherapeutic implications. Int J Antimicrob Agents (2003) 0.94
Contribution of the multidrug efflux pump LfrA to innate mycobacterial drug resistance. FEMS Microbiol Lett (2000) 0.94
Modulation of expression of multidrug resistance gene (mdr-1) by adriamycin. FEBS Lett (1992) 0.81
Benzothiazinones kill Mycobacterium tuberculosis by blocking arabinan synthesis. Science (2009) 3.39
High content screening identifies decaprenyl-phosphoribose 2' epimerase as a target for intracellular antimycobacterial inhibitors. PLoS Pathog (2009) 2.76
Global analysis of the Mycobacterium tuberculosis Zur (FurB) regulon. J Bacteriol (2006) 2.33
Role of mycobacterial efflux transporters in drug resistance: an unresolved question. FEMS Microbiol Rev (2006) 2.02
New tuberculosis drugs on the horizon. Curr Opin Microbiol (2011) 1.94
Structural basis for benzothiazinone-mediated killing of Mycobacterium tuberculosis. Sci Transl Med (2012) 1.78
Rv2686c-Rv2687c-Rv2688c, an ABC fluoroquinolone efflux pump in Mycobacterium tuberculosis. Antimicrob Agents Chemother (2004) 1.64
The multidrug transporters belonging to major facilitator superfamily in Mycobacterium tuberculosis. Mol Med (2002) 1.58
MmpL3 is the cellular target of the antitubercular pyrrole derivative BM212. Antimicrob Agents Chemother (2011) 1.51
Benzothiazinones are suicide inhibitors of mycobacterial decaprenylphosphoryl-β-D-ribofuranose 2'-oxidase DprE1. J Am Chem Soc (2011) 1.33
Mycobacterium tuberculosis FurA autoregulates its own expression. J Bacteriol (2003) 1.32
Assessment of three Resistance-Nodulation-Cell Division drug efflux transporters of Burkholderia cenocepacia in intrinsic antibiotic resistance. BMC Microbiol (2009) 1.30
Mycobacterium tuberculosis: drug resistance and future perspectives. Future Microbiol (2009) 1.29
Efflux pump genes of the resistance-nodulation-division family in Burkholderia cenocepacia genome. BMC Microbiol (2006) 1.26
Azole resistance in Mycobacterium tuberculosis is mediated by the MmpS5-MmpL5 efflux system. Tuberculosis (Edinb) (2008) 1.24
mmpL7 gene of Mycobacterium tuberculosis is responsible for isoniazid efflux in Mycobacterium smegmatis. Antimicrob Agents Chemother (2005) 1.23
Molecular mechanisms of chlorhexidine tolerance in Burkholderia cenocepacia biofilms. Antimicrob Agents Chemother (2011) 1.22
The Mycobacterium tuberculosis Rv2358-furB operon is induced by zinc. Res Microbiol (2004) 1.19
Deciphering the role of RND efflux transporters in Burkholderia cenocepacia. PLoS One (2011) 1.14
Development of a repressible mycobacterial promoter system based on two transcriptional repressors. Nucleic Acids Res (2010) 1.13
Biological and structural characterization of the Mycobacterium smegmatis nitroreductase NfnB, and its role in benzothiazinone resistance. Mol Microbiol (2010) 1.12
Characterization of tetracycline resistance mediated by the efflux pump Tap from Mycobacterium fortuitum. J Antimicrob Chemother (2005) 1.09
Clinical isolates of Mycobacterium tuberculosis in four European hospitals are uniformly susceptible to benzothiazinones. Antimicrob Agents Chemother (2010) 1.05
The DprE1 enzyme, one of the most vulnerable targets of Mycobacterium tuberculosis. Appl Microbiol Biotechnol (2013) 1.04
Rv2358 and FurB: two transcriptional regulators from Mycobacterium tuberculosis which respond to zinc. J Bacteriol (2005) 1.02
Biofilm-grown Burkholderia cepacia complex cells survive antibiotic treatment by avoiding production of reactive oxygen species. PLoS One (2013) 1.01
Transcriptional analysis of ESAT-6 cluster 3 in Mycobacterium smegmatis. BMC Microbiol (2009) 0.97
Functional and genetic characterization of the tap efflux pump in Mycobacterium bovis BCG. Antimicrob Agents Chemother (2012) 0.95
Improved BM212 MmpL3 inhibitor analogue shows efficacy in acute murine model of tuberculosis infection. PLoS One (2013) 0.94
Contribution of the Rv2333c efflux pump (the Stp protein) from Mycobacterium tuberculosis to intrinsic antibiotic resistance in Mycobacterium bovis BCG. J Antimicrob Chemother (2007) 0.94
Characterization and heterologous expression of the oxalyl coenzyme A decarboxylase gene from Bifidobacterium lactis. Appl Environ Microbiol (2004) 0.93
Molecular approaches to pathogenesis study of Burkholderia cenocepacia, an important cystic fibrosis opportunistic bacterium. Appl Microbiol Biotechnol (2011) 0.90
Heterologous expression, purification, and enzymatic activity of Mycobacterium tuberculosis NAD(+) synthetase. Protein Expr Purif (2002) 0.87
Analogous mechanisms of resistance to benzothiazinones and dinitrobenzamides in Mycobacterium smegmatis. PLoS One (2011) 0.86
Evaluation of fluoroquinolone resistance mechanisms in Pseudomonas aeruginosa multidrug resistance clinical isolates. Microb Drug Resist (2011) 0.86
Exploring the HME and HAE1 efflux systems in the genus Burkholderia. BMC Evol Biol (2010) 0.85
Structural plasticity and distinct drug-binding modes of LfrR, a mycobacterial efflux pump regulator. J Bacteriol (2009) 0.85
Rv2466c mediates the activation of TP053 to kill replicating and non-replicating Mycobacterium tuberculosis. ACS Chem Biol (2014) 0.83
Design, chemical synthesis of 3-(9H-fluoren-9-yl)pyrrolidine-2,5-dione derivatives and biological activity against enoyl-ACP reductase (InhA) and Mycobacterium tuberculosis. Eur J Med Chem (2013) 0.83
Genomic analysis of zinc homeostasis in Mycobacterium tuberculosis. FEMS Microbiol Lett (2008) 0.83
Mechanism of action of 5-nitrothiophenes against Mycobacterium tuberculosis. Antimicrob Agents Chemother (2014) 0.83
4-aminoquinolone piperidine amides: noncovalent inhibitors of DprE1 with long residence time and potent antimycobacterial activity. J Med Chem (2014) 0.82
A census of RND superfamily proteins in the Burkholderia genus. Future Microbiol (2013) 0.82
Mechanism of resistance to an antitubercular 2-thiopyridine derivative that is also active against Burkholderia cenocepacia. Antimicrob Agents Chemother (2014) 0.82
Glutamine amidotransferase activity of NAD+ synthetase from Mycobacterium tuberculosis depends on an amino-terminal nitrilase domain. Res Microbiol (2005) 0.81
1,5-Diaryl-2-ethyl pyrrole derivatives as antimycobacterial agents: design, synthesis, and microbiological evaluation. Eur J Med Chem (2009) 0.80
Control of MRSA infection and colonisation in an intensive care unit by GeneOhm MRSA assay and culture methods. BMC Infect Dis (2009) 0.79
Retracted Antituberculars which target decaprenylphosphoryl-β-D-ribofuranose 2'-oxidase DprE1: state of art. Appl Microbiol Biotechnol (2012) 0.79
1,5-Diphenylpyrrole derivatives as antimycobacterial agents. Probing the influence on antimycobacterial activity of lipophilic substituents at the phenyl rings. J Med Chem (2008) 0.79
Mycobacterium tuberculosis phosphoribosylpyrophosphate synthetase: biochemical features of a crucial enzyme for mycobacterial cell wall biosynthesis. PLoS One (2010) 0.78
Chemical synthesis and biological evaluation of triazole derivatives as inhibitors of InhA and antituberculosis agents. Eur J Med Chem (2012) 0.78
Synthesis and evaluation of α-ketotriazoles and α,β-diketotriazoles as inhibitors of Mycobacterium tuberculosis. Eur J Med Chem (2013) 0.77
Single-cell analysis of mycobacteria using microfluidics and time-lapse microscopy. Methods Mol Biol (2015) 0.77
Synthesis and biological activities of triazole derivatives as inhibitors of InhA and antituberculosis agents. Eur J Med Chem (2011) 0.77
Techniques and applications: The heterologous expression of Mycobacterium tuberculosis genes is an uphill road. Trends Microbiol (2003) 0.76
DprE1, a new taxonomic marker in mycobacteria. FEMS Microbiol Lett (2013) 0.76
Identification and characterization of a new ligand-binding site in FnbB, a fibronectin-binding adhesin from Streptococcus dysgalactiae. Biochim Biophys Acta (2003) 0.75
A phenotypic based target screening approach delivers new antitubercular CTP synthetase inhibitors. ACS Infect Dis (2017) 0.75
Synthesis and anti-mycobacterial activities of triazoloquinolones. Eur J Med Chem (2010) 0.75
Iron Acquisition Pathways as Targets for Antitubercular Drugs. Curr Med Chem (2016) 0.75